Loading...
XNASUTMD
Market cap210mUSD
Jan 16, Last price  
61.99USD
1D
-1.40%
1Q
-6.50%
Jan 2017
-14.79%
Name

Utah Medical Products Inc

Chart & Performance

D1W1MN
XNAS:UTMD chart
P/E
12.64
P/S
4.19
EPS
4.90
Div Yield, %
2.04%
Shrs. gr., 5y
-0.60%
Rev. gr., 5y
3.64%
Revenues
50m
-3.93%
26,485,00027,692,00028,753,00028,502,00027,782,00025,916,00025,121,00037,860,00041,552,00040,493,00041,278,00040,157,00039,298,00041,414,00041,998,00046,904,00042,178,00049,054,00052,281,00050,224,000
Net income
17m
+0.98%
10,220,0007,547,0008,168,0007,905,0007,205,0006,258,0006,014,0007,414,00010,169,00011,406,00011,378,00011,843,00012,128,0008,505,00018,554,00014,727,00010,798,00014,788,00016,473,00016,635,000
CFO
22m
+5.36%
27,459,0006,451,00010,853,0007,474,0007,762,0007,226,0007,157,00011,365,00013,563,00012,309,00015,387,00013,801,00014,528,00016,908,00016,834,00017,056,00020,137,00021,203,00021,147,00022,281,000
Dividend
Sep 20, 20240.3 USD/sh
Earnings
Jan 28, 2025

Profile

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
IPO date
Dec 01, 1982
Employees
186
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
50,224
-3.93%
52,281
6.58%
Cost of revenue
33,447
32,491
Unusual Expense (Income)
NOPBT
16,777
19,790
NOPBT Margin
33.40%
37.85%
Operating Taxes
3,454
4,186
Tax Rate
20.59%
21.15%
NOPAT
13,323
15,604
Net income
16,635
0.98%
16,473
11.39%
Dividends
(4,282)
(3,163)
Dividend yield
1.40%
0.86%
Proceeds from repurchase of equity
(2,378)
(2,321)
BB yield
0.78%
0.63%
Debt
Debt current
54
Long-term debt
590
682
Deferred revenue
549
Other long-term liabilities
698
1,463
Net debt
(92,278)
(74,316)
Cash flow
Cash from operating activities
22,281
21,147
CAPEX
(639)
(818)
Cash from investing activities
(639)
(818)
Cash from financing activities
(4,165)
(5,484)
FCF
13,541
15,445
Balance
Cash
92,868
75,052
Long term investments
Excess cash
90,357
72,438
Stockholders' equity
127,719
114,003
Invested Capital
38,949
43,792
ROIC
32.20%
32.87%
ROCE
12.83%
16.81%
EV
Common stock shares outstanding
3,637
3,643
Price
84.22
-16.22%
100.53
0.53%
Market cap
306,308
-16.36%
366,231
0.06%
EV
214,030
291,915
EBITDA
23,145
26,872
EV/EBITDA
9.25
10.86
Interest
869
Interest/NOPBT
4.39%